PentaBind

Shutdown

Website unreachable since Oct 26, 2026

PentaBind utilizes Generative AI and aptamers to enhance drug discovery and diagnostics in biotechnology. The company focuses on improving the accuracy and efficiency of identifying potential therapeutic candidates and diagnostic tools, addressing the high costs and lengthy timelines associated with traditional methods.

Traction 8/10

HQ unknown

Founded 2021112K+ followers

Artificial Intelligence
Biotechnology

Updated 7 months ago

Funding

Raised to date

$845KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

3 founders

Rory Ryan

CEO

Miguel Gonzalez Canudas

Chief AI Officer

Phil Haynes

Co-Founder

Product

Features

PentaBind utilizes Generative AI and aptamers to enhance drug discovery and diagnostics in biotechnology. The company focuses on improving the accuracy and efficiency of identifying potential therapeutic candidates and diagnostic tools, addressing the high costs and lengthy timelines associated with traditional methods.